| Serial Number | 97193007 |
| Word Mark | NOBRXIOL |
| Filing Date | Tuesday, December 28, 2021 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Monday, May 15, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Cannabidiol intranasal spray for treatment of epilepsy |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 4, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Virpax Pharmaceuticals Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Berwyn, PA 19312 |
| Event Date | Event Description |
| Monday, May 15, 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Monday, May 15, 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Monday, May 15, 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Monday, October 31, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, October 31, 2022 | NON-FINAL ACTION E-MAILED |
| Monday, October 31, 2022 | NON-FINAL ACTION WRITTEN |
| Saturday, October 29, 2022 | ASSIGNED TO EXAMINER |
| Friday, September 30, 2022 | ASSIGNED TO EXAMINER |
| Thursday, September 29, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, January 4, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, December 31, 2021 | NEW APPLICATION ENTERED |